product development commercial product supply supply chain management development phase early development late development approval and post approval life cycle management about us company profile our history leadership sites quality our clients our commitments faqs news & press events investor relations careers ideas in action ask the experts brochures & scientific posters articles & white papers videos recorded webcasts close solutions & services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval and post approval life cycle management about us company profile our history leadership sites quality our clients our commitments faqs news & press events investor relations careers ideas in action ask the experts brochures & scientific posters articles & white papers videos recorded webcasts menu menu solutions & services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval and post approval life cycle management about us company profile our history leadership sites quality our clients our commitments faqs news & press events investor relations careers ideas in action ask the experts brochures & scientific posters articles & white papers videos recorded webcasts what s new news events articles videos reduce your risks instead of your return . now that s biological . 11 october 2016 patheon announces the retirement of stuart grant share connect with patheon today on july 21 2016 patheon became a publicly traded company on the new york stock exchange nyse under the trading symbol pthn . 24 october 2016 26 october 2016 ausbiotech 2016 share 4 august 2016 patheon announces full redemption of 8.75 % 9.50 % senior pik toggle notes due may ... share customized solutions adaptable capacity . welcome to truly flexible manufacturing . 3 november 2016 4 november 2016 highly potent active pharmaceutical ingredients summit share discover how patheon has the innovation and expertise to transform the pharma industry . the knowledgeable experts at patheon are here to answer your questions submit your inquiry let s find a solution . 7 november 2016 9 november 2016 bio europe share 26 july 2016 patheon n.v. announces closing of initial public offering and full exercise of u. . . share this is where your discoveries take form . learn more about the solid and sterile dose forms available at patheon . welcome to getting solubility right the first time . welcome to phase ahead . linkedin twitter see how patheon onesource accelerates every step of drug development and more importantly eliminates the spaces between them . see patheon at a glance . share connect we look forward to learning about your specific needs please contact us . solutions & services biologics small molecules product development commercial product supply supply chain management development phase early development late development approval & post approval life cycle management about us company profile investor relations our history leadership sites quality our clients our commitments faqs news & press events careers working at patheon job opportunities connect for clients for investors for media members for job seekers ideas in action ask the experts brochures & scientific posters articles & white papers videos recorded webcasts 2016 patheon terms of use privacy statement patheon.jp